Taking the right chances
Regulatory reach is extending further, the price we might have to pay for growth is higher than ever and, economically, we’re still on uncertain ground. Is it all worth the risk?
adapt and evolve
Risk, as we once knew it, has changed. When a crisis hits, the pressure to respond is enormous. Companies need to be prepared.
We need to address Europe’s failing economic policy, argue Alistair Darling and Peter Bofinger.
The future of healthcare is here
Digital healthcare, the convergence of life sciences and technology, is transforming medicine and revolutionizing global markets
Digital healthcare in numbers
Key findings from our survey: from remote monitoring and “mHealth” to data privacy and IP issues
Taking the pulse of digital healthcare
Nine out of ten companies say digital healthcare plays a key role in their overall business strategy – underlining the opportunities emerging from this sector
The keys to digital healthcare success
How are companies planning to increase their investment in digital healthcare, and what practical obstacles stand in their way?
When giants meet—the convergence of life sciences and tech
Infographic: comparing the digital healthcare strategies of technology and life sciences companies
Meeting of minds
How can technology and life sciences companies come together, and what challenges do both sides expect to face?
Privacy, patents and property
To succeed in digital healthcare, technology and life sciences companies need to understand data privacy, intellectual property and other important legal issues
Fast-forward to a digital future
Six key insights that future leaders in digital healthcare should begin exploring immediately
In summer 2015, Mergermarket surveyed 120 US-based senior-level executives split equally between the technology and life sciences sectors. All respondents confirmed that they were responsible for their company’s digital healthcare strategy, and all respondents from the technology sector confirmed that their company had invested or was considering investing in a healthcare-related sector. Corporate revenues of respondent companies were split equally between US$1 – 5 billion and more than US$5 billion. The survey included a combination of qualitative and quantitative questions, and all interviews were conducted over the telephone by appointment. Results were analyzed and collated by Mergermarket, and all responses are anonymized and presented in aggregate.
The cutting edge: Shaping the future of digital healthcare
Digital healthcare, the convergence between life sciences and information technology, is revolutionizing global markets